Primary care providers are charged with distinguishing children with an underlying growth problem from those with healthy variant short stature. Knowing the heights of the biological parents aids in making that decision. This study sought to determine the feasibility and functionality of an electronic mid-parental height (MPH) auto-calculator in the clinical assessment of child growth in a pediatric primary care setting. Clinicians completed surveys for 62% of 6803 children (mean height 13 ± 7 percentile) with recorded parent heights. Collecting parent height data required <30 seconds in 91% of encounters. The MPH tool confirmed clinicians' initial growth assessment in 79% of cases and changed it in 4%; the remainder did not use the tool. Clinicians who changed assessment were more likely (P < .0001) to pursue more comprehensive evaluation. The MPH tool was a quick, functional resource as a component of an electronic health record system in actual, busy, pediatric primary care practices.
1
Growth failure can be the first or only sign of serious disorders that include psychosocial, nutritional, genetic, and disease processes. 2 Primary care providers (PCPs) are charged with distinguishing children with an underlying growth problem from those with healthy variant short stature and deciding which patients need further evaluation and/or referral for subspecialist care.
Knowing the heights of the biological parents aids in making that decision. In general, tall parents produce tall children and short parents short children. Therefore, a child at the 5th percentile for height is probably growing as expected if the parents are themselves 5th percentile or likely pathologically small if parents are above average in height. 3 A caveat is the misclassification of familial short stature for a short child who shares a dominantly inherited growth problem with their abnormally short, undiagnosed parent; a more extended family history will reveal the parent's height also to be atypical for their genetic background.
Thus, calculation of mid-parental height (MPH) has been recommended for assessing growth in individual children since it was first described in 1970. 3 Formulae (in cm) for calculating gender adjusted MPH are the following: for girls (father's height − 13 + mother's height)/2; and for boys (father's height + mother's height + 13)/2. Results of both formulae are reported ±10 cm (ie, ±2 SD). Using MPH to guide clinical decisions requires obtaining parental heights, making the calculation, and considering the results for the individual patient.
With the advent of electronic health record (EHR) systems, multiple tools have been developed to guide and facilitate clinical decision making. The use of EHR systems increased from 18% in 2001 to 57% in 2011 estimates among office-based physicians. 4 A 2009 nationwide survey of the American Academy of Pediatrics members practicing in office or clinic-based 614352C PJXXX10.1177/0009922815614352Clinical Pediatrics research-article2015 1 The Children's Hospital of Philadelphia, Philadelphia, PA, USA 2 University of Pennsylvania, Philadelphia, PA, USA settings found that although 54% reported using electronic medical records and 41% an EHR system, only 3% used a fully functional system that was pediatric supportive. 5 Pediatric-supportive EHR systems require additional functionality from those in adult medicine, such as growth monitoring, immunization tracking, and weight-based medication dosing support. 6 The purpose of this study was to determine the feasibility and functionality of an EHR tool using MPH autocalculation to support clinical decision making in the pediatric primary care setting. This study was performed in a network of primary care practices affiliated with a tertiary care pediatric hospital. A tool for calculating MPH was not previously available in the network EHR (EpicCare; Epic Systems Inc, Verona, WI), and the network leadership deemed that such an auto-calculator, by obviating the clinician's need to manually calculate MPH, in the least would improve practice by not requiring PCPs to remember correctly the 2 formulae, decreasing the time it took PCPs to obtain the results, and preventing arithmetic errors.
Methods
Approval for this study was obtained from the Children's Hospital of Philadelphia Institutional Review Board.
MPH Tool Development
The MPH tool was developed through a series of discussions that included pediatric PCPs, endocrine providers, computer programmers, a gastroenterologist, and biostatistician. To maximize tool and survey use, consideration of minimizing the time required by PCPs and practice staff was paramount in study design. To target the most pertinent patient encounters, the tool was programmed for well visits for patients with height below the 25th percentile. The study was limited to patients aged 2 years through 15 (girls) or 17 (boys) years, since older patients were likely to have stopped growing. Although measured height is recognized as more accurate than self-reported height, parent-reported heights were used to decrease impact on clinic flow. In practice, the MPH tool will more realistically and feasibly be used with reported heights as that is less time consuming than measuring heights and often only one parent is present at the visit. Finally, the survey was designed to be brief, with multiple-choice questions and responses ordered to facilitate ease of finding the appropriate choice.
The MPH calculator was created by our team using web-based technology. This approach permitted embedding of the calculator into the commercial EHR so it was easy to access by the clinicians in their standard preventive health care visit workflow. JavaScript (Oracle Corporation, Redwood City, CA) and Python (Python Software Foundation, Wilmington, DE) were used to implement the graphical user interface and height percentile calculations, respectively. Although clinicians perceived the calculator to be a part of the EHR, it was functionally independent and can be embedded in any of the growing number of EHRs that provide mechanisms for connecting externally developed web-based tools to their products. 7, 8 
Subjects
Thirteen pediatric primary care practices in Pennsylvania and New Jersey affiliated with a tertiary care children's hospital were invited to participate in this study. Nine practices volunteered, while 4 declined due to prior commitment to other research projects or a temporary staff shortage. Participating practices included both urban and nonurban locations. Each participating site received a new stadiometer and recumbent length board (both from Weigh and Measure, LLC, Olney, MD), as well as CMEand CNU-certified education sessions related to accurate measurement techniques, 9 growth assessment, and use of the MPH tool. Informed consent was obtained from the PCPs (physicians and nurse practitioners).
Intervention and Follow-up Evaluation
The MPH tool was programmed to appear in the EHR of the practices from September 1, 2010, to September 1, 2011, for patients meeting inclusion criteria; once completed, the tool would not reappear for that patient at subsequent visits within the study period. Prompted by the tool, the staff person measuring the child asked the accompanying adult to report the heights of the biological parents in either English or metric units. If only one parent was present, the parent self-reported their height and also reported the height of the absent parent. Measurers were asked to rate their confidence in the accuracy of the parent-reported heights based on observation of the parent and their difficulty in responding to the question. "Very confident" was selected in cases when a single height was quickly and assuredly provided, "close estimate" referred to episodes wherein a parent said their height was within a 2-inch range (eg, "I am 5'3" or 5'4"."), or "large guess" was selected for responses such as, "I am 5'2". My husband is taller than me. Therefore, he must be 6' tall." There was also an option to enter "height not known," such as for adopted or foster children. Clinic staff was also asked to indicate the length of time required to obtain the parental height data. The program auto-calculated both the gender-adjusted MPH and its corresponding percentile ( Figure 1A ).
The well visits proceeded per routine. However, PCPs had access during the visits to the MPH tool, including parent heights, MPH calculations, and confidence ratings ( Figure 1A ), to use as they deemed appropriate. At the completion of the visit, PCPs were asked to complete a brief electronic survey about their use of the tool and their assessment and disposition related to the child's growth ( Figure 1B ).
Once the tool was launched, the study team met monthly to review implementation of the tool, confirm that it was triggered only for children meeting inclusion criteria, and to address any performance concerns as needed. Participating practices were emailed monthly updates on the aggregated survey response rates of their PCPs as well as rates for the other anonymized participating practices. Study personnel visited the primary care sites quarterly to provide assistance, and were also available by telephone and email throughout the study.
Data Collection and Analyses
In addition to data entered in the tool and survey, data extracted from the EHR included the patient's height percentile, gender, age, race/ethnicity, and type of insurance. Descriptive statistics, contingency tables, and logistic regression model parameters were estimated using JMP Software (SAS Institute, Carey, NC). For continuous variables, mean, standard deviation (SD), 95% confidence interval (CI), median, and interquartile range are reported, and for discrete categories, frequency counts and percentages are tabulated. For multivariable logistic regression models, odds ratio (OR) and 95% CI indicate the contributions of candidate explanatory variables to the outcome; range odds ratios are presented for continuous variables in the model.
A priori, feasibility of the tool was defined as the ability to complete the MPH assessment (as the tool auto calculates the MPH values instantaneously, this corresponds to the time needed to collect parental height data) in less than 1 minute for at least 90% of patients. Functionality of the tool was defined as clinician use of the MPH tool data in clinical decision making for at least 75% of patients who had parental height data collected. Clinician use was assessed by self-report in real 
Results

Patient Population
A total of 6803 patients of 70 PCPs met age inclusion criteria and were measured as below the 25th percentile, thereby activating the MPH tool. The study patient population was 54% male, with mean age 8.9 ± 4.5 years, and distributed 60% white, 24% African American, 13% Other, 4% Hispanic, and 3% Asian. Private insurance was held by 71%, 27% received Medicaid, and 2% were self-pay.
Collecting Reported Parental Heights
Parental heights were available for 6338 (93%) mothers, 6197 (91%) fathers, and 6173 (91%) parental pairs. Clinic staff collecting the data gave "very confident" ratings to the reliability of heights reported for 76% of mothers and 58% of fathers. Logistic regression modeling indicated that a very confident rating was associated with patient race/ethnicity and age, insurance coverage, and parental height; patient gender was also a significant explanatory variable in modeling the confidence ratings of reported maternal heights (Table 1 ). Clinic staff reported that it took less than 30 seconds to obtain the parental height data for 91% of encounters. The time required was 30 to 60 seconds for 6%, and more than 60 seconds for 3% of encounters.
Distributions of Patients' and Parents' Heights
As expected from our inclusion criteria, patient heights ranged from the 1st to 24th percentile. Mean ± SD percentile height of the children was 13 ± 7, while median and interquartile range was 14 [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . MPH ranged from the 1st to 95th percentiles. Mean ± SD percentile MPH was 39 ± 24, while median and interquartile range was 35 [18-56].
MPH Tool Use by PCP
Providers completed surveys on 62% of the encounters of children who had MPH recorded, reporting in real-time the impact of the tool on their clinical decision-making (Table 2) . Eighty-three percent of those who completed the survey reported use of the MPH tool. Providers While measuring patients, clinic staff collected parental heights by self-or partner-report and rated their confidence in the accuracy of the heights as "very confident," "close estimate," or "large guess"; "height not known" was also an option.
reported not using the MPH tool because they viewed the data as unreliable (10%) or for other reasons (7% . Providers' assessment of children with height below the 25th percentile was that 54% were short but normal height and velocity for their family, 35% had a normal height and velocity for the population, 4% were short or had decreased velocity likely due to socioeconomic or dietary factors, and 7% were short or had decreased velocity, possibly due to an underlying disease process.
Disposition by MPH Tool Use
PCPs who reported using the tool, and for whom the tool confirmed their assessment, were most likely to continue routine growth-related surveillance only (Table 2) . Although routine growth-related surveillance was also the disposition most frequently selected by PCPs who changed their assessment or did not use the MPH tool, this was decreased relative to PCPs whose assessments were confirmed by the MPH tool. PCPs who reported changing their assessment were more likely to have made the decision to monitor growth more frequently (P < .0001), recommend nutritional changes (P < .0001), order diagnostic tests (P < .0001), or refer to endocrinology (P < .0001) or to gastroenterology (P < .005) when compared to PCPs who stated that the tool confirmed their decision making or to PCPs who did not use the tool. PCPs who indicated that they did not use the tool for reason other than unreliable or incomplete parental height data were most likely to select, "previously diagnosed condition, ± under treatment, continue current treatment."
Discussion
In summary, the MPH tool was both a feasible and functional component of an EHR in actual, busy, pediatric primary care settings. In 97% of the encounters (study target 90%), clinic staff collected and rated the reported parental height data needed for calculating MPH in less than 1 minute. PCPs utilized the MPH tool information to assess 83% (study target 75%) of the patients for whom parental heights were entered, either changing or confirming their clinical assessment. Tool use affected clinical decision making, as evident in differences in PCP dispositions for the patients. When the tool changed PCP decision making (4% of patients), it led to increased monitoring, nutritional care change, diagnostic tests, and subspecialist referrals. Thus, it seemingly alerted PCPs to a potential problem. Patients for whom the MPH tool changed their PCP's assessment were shorter and had taller parents, congruent with the traditional teaching that children who are short relative to their genetic potential are more likely to have an underlying growth problem. PCPs were also more likely to change their assessment and pursue more comprehensive evaluation for male patients. Similarly, previous studies reported a greater frequency of diagnostic testing of growth hormone system function by PCPs for male rather than female patients with growth faltering, 10 and a male predominance among children referred to endocrine centers for evaluation of short stature. 11 Conversely, when MPH tool use confirmed the clinical assessment of PCPs (79% of patients), they were most likely to pursue only routine growth surveillance (83%) compared with PCPs who chose routine monitoring but did not use the tool because of issues with parental heights (72%), or did not use for other reasons (66%). Thus, the tool seemed to provide a mechanism of reassurance, possibly preventing unnecessary testing and referrals. The 2 common reasons for not using the MPH tool were incomplete or unreliable parental height data and cases where the clinician was aware of a previously diagnosed condition under treatment. Parental heights are most commonly obtained by self-report. Studies have shown that self-reported height data may be inaccurate. [12] [13] [14] Males were more likely to overestimate height by an average of 1.6 to 2.5 cm and women by an average of 0.5 to 1.0 cm. [12] [13] [14] Partner reported height of fathers was overestimated even more.
14 The factor most associated with reported inaccuracies was age, with older adults (>45 years) significantly more unreliable. 13 Interestingly, practice staff in our study were least confident in the reported heights of white parents with private insurance. Data have shown that individuals in positions of power overestimate their own height 15 and that parents of white pediatric primary care patients reported higher acceptable height thresholds than parents of other races/ethnicities. 16 Although self-or partner-reported heights may be inaccurate, the study design was based on reported, rather than measured, parental heights in consideration of the time constraints of the primary care practice settings. The study protocol reflected current clinical practice; hence, the results are likely more generalizable. We also asked the clinic staff to rate their confidence in the reliability of the reported parent heights. This quick observation alerted PCPs to heights that were more suspect and, therefore, allowed better interpretation of the data without impeding clinic flow. Inaccurate parental height reporting was a limitation of data collected, rather than with the MPH calculator itself and its clinical interpretation. For those providers who do not have confidence in the reported heights of parents, or if accuracy of parental heights is integral to decision making, parental heights should be measured with a stadiometer at the clinic visit.
Beyond the issue of parental height collection, there are other limitations of this study. We do not have data on why some PCPs chose not to use the tool. All pediatric practices in the study were associated with a researchintensive tertiary care center. However, diversity of practice cultures within this network ranges from suburban practices that follow a private practice model to urban academic practices that provide resident education. Nevertheless, degree of MPH tool utilization may be different in other types of primary care practices. Also, in this study setting, it was not possible to determine if the PCPs' assessments of the short children, or their dispositions, were appropriate. The MPH tool resulted in an altered plan for 4% of the patients, but it is not known if the change resulted in better clinical care. The purpose of this study was to determine the feasibility and functionality of the tool, and future research will focus on whether altered decisions based on consideration of the MPH tool result are appropriate.
In conclusion, our study demonstrated the feasibility and functionality of an EHR-based MPH auto-calculator in pediatric primary care, so much so that it contributed to the implementation of MPH auto-calculation functionality in a vendor-supplied EHR system. Use of the MPH calculator tool negligibly affected patient flow, requiring less than 30 seconds to complete, and such data collection need occur only once in the care history of each patient since MPH does not change over time. These data are the first to demonstrate that use of an EHR-based MPH calculator affected clinical decisionmaking. To our knowledge, this is also the first evidence that calculated gender-adjusted MPH was used by PCPs as it was originally proposed by Tanner-both to prompt further evaluation for children at highest risk (ie, identify children with a height deficit relative to their genetic potential) and to provide reassurance for children who may not need additional monitoring. Auto-calculation of MPH that was integrated into the EHR system was helpful to pediatric PCPs and has the potential to improve growth evaluation in children.
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